Ruxolitinib reverses systemic vasculitis driven by JAK2 V617F-mutated essential thrombocythemia: a case report. [PDF]
Ashida Y +14 more
europepmc +1 more source
Novel strategies targeting mutant calreticulin in essential thrombocythemia and myelofibrosis. [PDF]
Salzman GS, Mullally A.
europepmc +1 more source
Impact of thrombosis on disease progression, cancer and mortality in patients with essential thrombocythemia and polycythemia vera. [PDF]
Angona A +31 more
europepmc +1 more source
Case Report: Chronic myeloid leukemia masquerading as essential thrombocythemia in a child: the imperative for early BCR::ABL1 testing in isolated thrombocytosis. [PDF]
He H, Fu J.
europepmc +1 more source
`Inflammatory mediators differentially regulate megakaryopoiesis and thrombopoiesis in myelofibrosis and essential thrombocythemia. [PDF]
Yañuk DB +12 more
europepmc +1 more source
Response to therapy and prognosis according to molecular characterization in <i>CALR</i>-mutated essential thrombocythemia. [PDF]
Santaliestra M +28 more
europepmc +1 more source
Physiological MplW514L expression in hematopoietic stem cell causes an essential thrombocythemia and progressive myelofibrosis. [PDF]
Zhang S +11 more
europepmc +1 more source
Coexistence of Essential Thrombocythemia and Waldenström Macroglobulinemia: A Case Report. [PDF]
Wallace M +4 more
europepmc +1 more source
Phase 2 study of the lysine-specific demethylase 1 inhibitor bomedemstat for essential thrombocythemia. [PDF]
Gill H +21 more
europepmc +1 more source
Dysplastic Megakaryocytes in a Gallbladder Neck Lymph Node in a Patient With Essential Thrombocythemia: A Case Report. [PDF]
Balcı M.
europepmc +1 more source

